GAD1 and aceruloplasminemia: Patient 15 had been diagnosed with anti-GAD cerebellar ataxia seven years earlier, receiving corticosteroid therapy and rituximab in the first 3 years of the disease, but later suspended because of a lack of relevant therapeutic effect.